Emil Lou, MD, PhD, FACP

After completing undergraduate studies in biochemistry at SUNY College at Geneseo, Dr. Lou received his M.D. and Ph.D. degrees (Microbiology and Immunology) from SUNY Upstate Medical University in 2004. He performed his residency training in Internal Medicine at Duke University Medical Center and then subsequently completed his Medical Oncology and Hematology fellowship at the Memorial Sloan-Kettering Cancer Center in 2010. He also completed an additional fellowship in Neuro-Oncology at the Preston Robert Tisch Brain Tumor Center at Duke.

Dr. Lou, a diplomate of the American Board of Internal Medicine, is board certified in Medical Oncology and Internal Medicine. In addition he is also board certified in Neuro-Oncology through the United Council for Neurologic Subspecialties. He joined the faculty in the Division of Hematology, Oncology and Transplantation in 2011 and is a member of the Masonic Cancer Center, University of Minnesota.

Care Philosophy

New Patients

• If you are scheduled or interested in scheduling a clinic consultation with Dr. Lou, click here for more information and a welcome from Dr. Lou.

Tips to be a Great Patient Advocate

• Dr. Lou's interview with Caringbridge.org

• ASCO Leadership Development Program (2021-2022)
• American Association for Cancer Research Emeritus Mentor Award, for service to the AACR’s Scientist<->Survivor Program, (April 2017)
• Minnesota Monthly magazine’s list of Top Doctors (2015, 2017, 2018)
• Selected by peers to Minnesota Monthly magazine's list of Best Doctors (2015)
• Early Career Development Award from the Central Society for Clinical and Translational Research (2015)
• 2015 Featured New Investigator Award from the CSCTR for meritorious paper published in Translational Research (2015)
• Distinguished Alumnus, State University of New York (SUNY) Upstate Medical University (2014)
• KL2 Scholar, KL2 Scholars Career Development Program, Clinical and Translational Science Institute (CTSI), University of Minnesota (2013 - 2016)
• Conquer Cancer Foundation Oncology Trainee Travel Award. American Society of Clinical Oncology (2011)
• AACR-GlaxoSmithKline Clinical Scholars Award (2010)
• AACR-Aflac, Inc. Scholar-in-Training Award, American Association for Cancer Research (2007)
• John Bernard Henry Endowed Fellowship Award, SUNY Upstate Medical University (2004)
• American Head and Neck Society Trainee Award (2002)

• Fellow of the American College of Physicians (FACP), American College of Physicians-American Society of Internal Medicine, 2015 to present
• Big Ten Cancer Research Consortium; GI Cancer Working Group Member 2014 to present
• Tumor Microenvironment Program, Masonic Cancer Center, University of Minnesota, 2014 to present
• Institute for Engineering in Medicine, University of Minnesota, 2014 to present  
• ASCO Scientific Program Committee Member, Gastrointestinal (Noncolorectal) Cancer track (2012-2015)
• Scientist Mentor, AACR Scientist <--> Survivor Program (2013-2017, 2019-2021)
• Member, American Association for Cancer Research
• Member, American Society of Clinical Oncology
• Member, Masonic Cancer

• Role of tunneling nanotubes in intercellular communication and pathophysiology of cancer. 
• Biomarkers of drug resistance in cancer
• Genomic markers of exceptional response or non-response to drug therapy in solid tumor malignancies (colorectal cancer and malignant brain tumors)